Background/Aims: Establish a reliable rabbit dry eye (DE) model. Methods: An interventional cohort study surgically removing glands contributing to the tear film. Eight rabbits were studied after removal of left lacrimal, Harderian, or both glands. Additional rabbits had Meibomian glands in the left eye thermally obstructed. All were followed for 10 weeks with phenol red thread (PRT) and slit-lamp examination with 2% fluorescein. We assessed corneal sensitivity using a Cochet-Bonnet esthesiometer. Outcome measures were severity/duration of reduced PRT, punctate epithelial erosions (PEE), and histologic evidence of corneal pannus. Results: Fluorescein staining demonstrated signs of dryness including PEE in all of the interventional eyes. The subjective measurement of epithelial erosions correlated with decreased tear production. PRT measurements in the control eyes averaged 31.54 mm (±1.83) and 22.71 mm (±1.60) in the eight left eyes, without loss of corneal sensitivity. Conclusions: Surgical removal of either the Harderian or lacrimal gland results in statistically significant decreases in tear volume and the development of severe DE. Removal of both glands results in the occurrence of a DE of comparable severity/duration to removal of either the lacrimal or Harderian gland alone. Meibomian gland obstruction contributes less to the DE model.

1.
Moshirfar M, Pierson K, Hanamaikai K, Santiago-Caban L, Muthappan V, Passi SF: Artificial tears potpourri: a literature review. Clin Ophthalmol 2014;8:1419-1433.
2.
Albert DM, Frayer WC, Black HE, Massicotte SJ, Sang DN, Soque J: The harderian gland: its tumors and its relevance to humans. Trans Am Ophthalmol Soc 1986;84:321-341.
3.
Hillenius WJ, Phillips DA, Rehorek SJ: “A new lachrymal gland with an excretory duct in red and fallow deer” by Johann Jacob Harder (1694): English translation and historical perspective. Ann Anat 2007;189:423-433.
4.
Payne AP: The harderian gland: a tercentennial review. J Anat 1994;185:1-49.
5.
Bayraktaroglu AG, Ergun E: Histomorphology of the Harderian gland in the Angora rabbit. Anat Histol Embryol 2010;39:494-502.
6.
Miyazaki M, Kim HJ, Weng CM, Ntambi JM: Oleoyl-CoA is the major de novo product of stearoyl-CoA desaturase 1 gene isoform and substrate for the biosynthesis of the Harderian gland 1-alkyl-2,3-diacylglycerol. J Biol Chem 2001;276:39455-39461.
7.
Gilbard JP, Rossi SR, Gray KL: A new rabbit model for keratoconjuntivitis sicca. Invest Ophthalmol Vis Sci 1987;28:225-228.
8.
Gilbard JP, Rossi SR, Heyda KG: Tear film and ocular surface changes after closure of the meibomian gland orifices in the rabbit. Ophthalmology 1989;96:1180-1186.
9.
Barabino S, Dana MR: Animal models of dry eye: a critical assessment of opportunities and limitations. Invest Ophthalmol Vis Sci 2004;45:1641-1646.
10.
Chen Z, Liang QF, Yu GY: Establishment of a rabbit model for keratoconjunctivitis sicca. Cornea 2011;30:1024-1029.
11.
Li N, Deng X, Gao Y, Zhang S, He M, Zhao D: Establishment of the mild, moderate, and severe dry eye models using three methods in rabbits. BMC Ophthalmology 2013;12:50.
12.
Arita R, Morishige N, Koh S, Shirakawa R, Kawashima M, Sakimoto T, Suzuki T, Tsubota K: Increased tear fluid production as a compensatory response to meibomian gland loss: a multicenter cross-sectional study. Ophthalmology 2015;122:925-933.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.